Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Thomas Simmet

Showing results (71-80 of 135) with videos related to

Pageof 14
Sort By:
Frontiers in Medicine|May 24, 2024
Exploring the gap: attitudes, knowledge, and training needs in complementary and integrative medicine among healthcare professionals at German university hospitalsDaniela Hesmert, Carina Klocke, Regina Stolz, et al.
Frontiers in Immunology|August 6, 2019
Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH PatientsMarkus J Harder, Britta Höchsmann, Arthur Dopler, et al.
Frontiers in Physiology|August 30, 2021
Regulation of NADPH Oxidase-Mediated Superoxide Production by Acetylation and DeacetylationNing Xia, Stefan Tenzer, Oleg Lunov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2009
Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasisHonglin Wang, Tatiana Syrovets, Daniel Kess, et al.
Parasitology Research|December 29, 2012
A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicumMiao Liu, Peng Chen, Berthold Büchele, et al.
Scientific Reports|May 4, 2017
The CAM cancer xenograft as a model for initial evaluation of MR labelled compoundsZhi Zuo, Tatiana Syrovets, Yuzhou Wu, et al.
Molecular Pharmacology|December 5, 2012
A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cellsSamy A F Morad, Maximilian Schmid, Berthold Büchele, et al.
EMBO Reports|June 23, 2017
Cellular mechanism of fibril formation from serum amyloid A1 proteinStephanie Claus, Katrin Meinhardt, Tobias Aumüller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1Arthur Dopler, Leonie Guntau, Markus J Harder, et al.
International Journal of Molecular Sciences|June 12, 2020
Chrysosplenol d, a Flavonol from <i>Artemisia annua</i>, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer CellsSophia J Lang, Michael Schmiech, Susanne Hafner, et al.
Pageof 14

Showing results (71-80 of 135) with videos related to

Sort By:
Pageof 14
Frontiers in Medicine|May 24, 2024
Exploring the gap: attitudes, knowledge, and training needs in complementary and integrative medicine among healthcare professionals at German university hospitalsDaniela Hesmert, Carina Klocke, Regina Stolz, et al.
Frontiers in Immunology|August 6, 2019
Different Levels of Incomplete Terminal Pathway Inhibition by Eculizumab and the Clinical Response of PNH PatientsMarkus J Harder, Britta Höchsmann, Arthur Dopler, et al.
Frontiers in Physiology|August 30, 2021
Regulation of NADPH Oxidase-Mediated Superoxide Production by Acetylation and DeacetylationNing Xia, Stefan Tenzer, Oleg Lunov, et al.
Journal of Immunology (Baltimore, Md. : 1950)|September 16, 2009
Targeting NF-kappa B with a natural triterpenoid alleviates skin inflammation in a mouse model of psoriasisHonglin Wang, Tatiana Syrovets, Daniel Kess, et al.
Parasitology Research|December 29, 2012
A boswellic acid-containing extract attenuates hepatic granuloma in C57BL/6 mice infected with Schistosoma japonicumMiao Liu, Peng Chen, Berthold Büchele, et al.
Scientific Reports|May 4, 2017
The CAM cancer xenograft as a model for initial evaluation of MR labelled compoundsZhi Zuo, Tatiana Syrovets, Yuzhou Wu, et al.
Molecular Pharmacology|December 5, 2012
A novel semisynthetic inhibitor of the FRB domain of mammalian target of rapamycin blocks proliferation and triggers apoptosis in chemoresistant prostate cancer cellsSamy A F Morad, Maximilian Schmid, Berthold Büchele, et al.
EMBO Reports|June 23, 2017
Cellular mechanism of fibril formation from serum amyloid A1 proteinStephanie Claus, Katrin Meinhardt, Tobias Aumüller, et al.
Journal of Immunology (Baltimore, Md. : 1950)|February 13, 2019
Self versus Nonself Discrimination by the Soluble Complement Regulators Factor H and FHL-1Arthur Dopler, Leonie Guntau, Markus J Harder, et al.
International Journal of Molecular Sciences|June 12, 2020
Chrysosplenol d, a Flavonol from <i>Artemisia annua</i>, Induces ERK1/2-Mediated Apoptosis in Triple Negative Human Breast Cancer CellsSophia J Lang, Michael Schmiech, Susanne Hafner, et al.
Pageof 14